| Model Number |
DTMB1QQ |
| Medical Device Problem Codes |
Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917)
|
| Health Effect - Clinical Code |
Shock from Patient Lead(s) (3162)
|
| Date of Event |
02/10/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: evproplus-26us transcatheter valve implanted: (b)(6) 2021 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient received an inappropriate shock for an episode detected in the ventricular fibrillation (vf) zone that was suspected to be ventricular tachycardia (vt).In addition, the right ventricular (rv) lead exhibited oversensing at the same time as the inappropriate shock.It was also noted that the right atrial (ra) lead exhibited undersensing triggering device classified false termination of atrial tachycardia/atrial fibrillation (at/af) event(s) and unnecessary pacing at times.The cardiac resynchronization therapy defibrillator (crt-d), rv lead, and ra lead remain in use.No further patient complications have been reported as a result of this event.
|
| |
|
Search Alerts/Recalls
|